MedPath
TGA Approval

TECENTRIQ atezolizumab (rch) 1200 mg/20 mL injection concentrated vial (277120)

277120

TECENTRIQ atezolizumab (rch) 1200 mg/20 mL injection concentrated vial

Roche Products Pty Ltd

July 27, 2017

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/390abfba5bb3fa787c40de192375f1a4.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/82439dfbb19e458dc53cd622c6b4633a.pdf

Active Ingredients

atezolizumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TECENTRIQ atezolizumab (rch) 1200 mg/20 mL injection concentrated vial (277120) - TGA 批准文号 | MedPath